OTC

Alongside the global pharma market, OTC supplements are expected to experience over a 6% compound annual growth rate for the next 5-plus years.

Educational interventions and pharmacist engagement enhance patient safety in OTC medication use, addressing knowledge gaps and promoting responsible self-care practices.

Following approval in 2023, researchers address lessons learned from the coalition- and movement-driven efforts to approve the first OTC oral contraceptive pill.

Pharmacists play a crucial role in preventing OTC drug abuse through proactive interventions and effective warning measures, according to recent research findings.

Pharmacy staff's confidence in the Senior Safe's effectiveness was the key factor leading to the success of managing OTC medication misuse among older adults.

OTC access expands, enhancing reproductive health and migraine relief while raising safety concerns about online pharmacies and medications like Benadryl.

A pharmacist's guidance is essential when selecting effective OTC cold and influenza medications that provide relief from symptoms such as cough, congestion, and fever.

Antibiotics are a prominent medication class reserved for helping patients fight bacterial infections.

With OTC drug abuse on the rise, particularly among young people, researchers want to better understand ways to prevent it.

In an exploration of the National Retail Data Monitor, researchers determine how OTC sales contributed to disease surveillance.

Study authors explore online purchasing habits for prescription-only and OTC medications.

Researchers explore OTC medication misuse among adults over 65 in Saudi Arabia.

With evidence of antiobesity properties in human trials, berberine could be an OTC phytotherapeutic option for weight loss.

Researchers investigate women’s experiences in accessing either prescription or OTC contraceptives.

Researchers explore OTC naloxone sales sold independently at pharmacies and programmatically from 2023 to 2024.

The FDA approves the Insti HIV Self Test, enabling rapid, accurate results in just one minute, enhancing access to HIV testing nationwide.

In the final part of our interview with Mark Garofoli, PharmD, BCGP, CPE, CTTS, he discusses what the future will hold regarding clinical decision-making following the reported acetaminophen-autism link.

Pain medication expert Mark Garofoli, PharmD, MBA, BCGP, CPE, CTTS, joined Drug Topics to explore the referenced studies in the Trump Administration’s push to link acetaminophen use with autism.

Mark Garofoli, PharmD, BCGP, CPE, CTTS, also known as “the Pain Guy,” discusses his initial reactions upon learning about the Trump Administration linking acetaminophen use with autism.

Detailing the public health impact of an Rx-to-OTC switch, researchers explored the reclassification of triptan medications in Germany.

The Signos Glucose Monitoring System uses body signals that help to improve sleep, manage weight, and decrease the risk of chronic disease.

Investigators found that Opill increased access for patients who were uninsured, identified as Black or Latina, had lower education, and lived in the Southern United States.

Experts call for the review of diphenhydramine and its possible replacement with second-generation antihistamines that have similar efficacy with fewer adverse events.

Whether it is a kitchen mishap or backyard injury, pharmacists are key in helping patients choose the right OTC first aid products for fast, effective care.

Allergy season is here. Help your patients tackle sneezing, itching, and congestion with this guide to the best OTC treatments.